A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Recruiting · NCT06297590 · Registry updated 2026-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Frontotemporal Lobar Degeneration, Pick disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, frontotemporal dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 1 | 2026-08-24 | NCT06297590 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CenExel AMRI | Toms River | United States | 2 |
| CenExel iResearch, LLC (CenExel iRA) | Decatur | United States | 2 |
| Charter Research, LLC | The Villages | United States | 2 |
| Duke University | Durham | United States | 160 |
| K2 Medical Research, LLC | Maitland | United States | 10 |
| Massachusetts General Hospital (MGH) | Charlestown | United States | 2 |
| National Hospital for Neurology and Neurosurgery (UCLH) | London | United Kingdom | 1 |
| Royal Hallamshire Hospital | Sheffield | United Kingdom | 18 |
| The University of Tokyo Hospital | Bunkyō City | Japan | 10 |
| University Hospital Southampton | Southampton | United Kingdom | 17 |